Sino Biopharmaceutical Ltd's Fiscal Year is From January To December - All Figures are in HKD, Millions.
The item "Depreciation-and-Amortization-Expense" stands at 366.51 Million Hong Kong Dollars for the trailing twelve months (TTM) period ending 03/31/2020, the lowest value since 03/31/2018.'
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -44.51 percent compared to the value the year prior.
The 1 year change in percent is -44.51.
The 3 year change in percent is 110.49.
The 5 year change in percent is 106.24.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Depreciation and Amortization Expense | 905,699,262,464.00 |
![]() | Johnson & Johnson - Depreciation and Amortization Expense | 486,508,953,600.00 |
![]() | AbbVie Inc - Depreciation and Amortization Expense | 399,570,305,024.00 |
![]() | Roche Holding AG - Depreciation and Amortization Expense | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Depreciation and Amortization Expense | 280,205,508,085.11 |